Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine3A receptor

Tina K. Machu, Margaret E. Hamilton, Tonia F. Frye, Christopher L. Shanklin, Michael C. Harris, Hongwei Sun, Thomas E. Tenner, Ferenc S. Soti, William R. Kem

Research output: Contribution to journalArticle

28 Scopus citations

Abstract

The nicotinic receptor drug candidate, 3-(2,4-dimethoxybenzylidene)-anabaseine (also known as GTS-21; DMXBA), its hydroxy metabolites, and some related analogs were evaluated with the two-electrode voltage-clamp technique in mouse 5-hydroxytryptamine (5-HT)3A receptors expressed in Xenopus oocytes. Although DMXBA lacked partial agonist activity, its hydroxy-benzylidene metabolites and related analogs were partial agonists, displaying the following rank order of potency (EC50) and apparent efficacy: 5-HT, 0.9 ± 0.06 μM (100% efficacy) > 3-(2-hydroxy,4-methoxybenzylidene)-anabaseine (2-OH-MBA), 2.0 ± 0.3 μM (63% efficacy) > 3-(2,4-dihydroxybenzylidene)-anabaseine, 2.6 ± 0.3 μM (63% efficacy) > 3-(2-methoxy,4-hydroxybenzylidene)-anabaseine, 17.2 ± 1.0 μM (30% efficacy). To examine the influence of a benzylidene ring hydroxy substituent, the agonist actions of the three possible monohydroxy isomers were examined. The rank order of potency, based on EC50 determinations, and apparent efficacy was: 3-(2-hydroxybenzylidene)-anabaseine, 20.3 ± 2.6 μM (63% efficacy) > 3-(4-hydroxybenzylidene)-anabaseine, 32.3 ± 5.9 μM (14% efficacy) > 3-(3-hydroxybenzylidene)-anabaseine (3-OH-BA) (no agonist activity). Both DMXBA and 3-OH-BA antagonized 5-HT-mediated currents, with IC50 values of 15.7 ± 0.9 and 27.5 ± 4.7 μM, respectively. DMXBA demonstrated both competitive and noncompetitive forms of antagonism over the range of concentrations tested. These results suggest that a hydroxy substituent at the 2′ position of the benzene ring is necessary and sufficient for partial agonist activity; substitution at the 4′ position with a hydroxy or methoxy group further enhances agonist potency. Because 2-OH-MBA is a primary metabolite of DMXBA, it may contribute to the physiological, biochemical, and behavioral effects of the parent compound when administered in vivo.

Original languageEnglish
Pages (from-to)1112-1119
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume299
Issue number3
StatePublished - 12 Dec 2001

Fingerprint Dive into the research topics of 'Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine<sub>3A</sub> receptor'. Together they form a unique fingerprint.

  • Cite this

    Machu, T. K., Hamilton, M. E., Frye, T. F., Shanklin, C. L., Harris, M. C., Sun, H., Tenner, T. E., Soti, F. S., & Kem, W. R. (2001). Benzylidene analogs of anabaseine display partial agonist and antagonist properties at the mouse 5-hydroxytryptamine3A receptor. Journal of Pharmacology and Experimental Therapeutics, 299(3), 1112-1119.